Literature DB >> 11694884

Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine.

M J Thomas1, C Beurrier, A Bonci, R C Malenka.   

Abstract

A compelling model of experience-dependent plasticity is the long-lasting sensitization to the locomotor stimulatory effects of drugs of abuse. Adaptations in the nucleus accumbens (NAc), a component of the mesolimbic dopamine system, are thought to contribute to this behavioral change. Here we examine excitatory synaptic transmission in NAc slices prepared from animals displaying sensitization 10-14 days after repeated in vivo cocaine exposure. The ratio of AMPA (alpha-amino-3-hydroxy-5-methyl-4- isoxazole propionic acid) receptor- to NMDA (N-methyl-d-aspartate) receptor-mediated excitatory postsynaptic currents (EPSCs) was decreased at synapses made by prefrontal cortical afferents onto medium spiny neurons in the shell of the NAc. The amplitude of miniature EPSCs at these synapses also was decreased, as was the magnitude of long-term depression. These data suggest that chronic in vivo administration of cocaine elicits a long-lasting depression of excitatory synaptic transmission in the NAc, a change that may contribute to behavioral sensitization and addiction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11694884     DOI: 10.1038/nn757

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  239 in total

Review 1.  A behavioral/systems approach to the neuroscience of drug addiction.

Authors:  Francis J White
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

2.  GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine.

Authors:  Zheng-Xiong Xi; Sammanda Ramamoorthy; Hui Shen; Russell Lake; Devadoss J Samuvel; Peter W Kalivas
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

3.  Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior.

Authors:  Krista McFarland; Christopher C Lapish; Peter W Kalivas
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

Review 4.  The reinstatement model of drug relapse: history, methodology and major findings.

Authors:  Yavin Shaham; Uri Shalev; Lin Lu; Harriet de Wit; Jane Stewart
Journal:  Psychopharmacology (Berl)       Date:  2002-10-26       Impact factor: 4.530

Review 5.  Glutamatergic signaling by midbrain dopaminergic neurons: recent insights from optogenetic, molecular and behavioral studies.

Authors:  Tibor Koos; Fatuel Tecuapetla; James M Tepper
Journal:  Curr Opin Neurobiol       Date:  2011-05-31       Impact factor: 6.627

Review 6.  Synaptic plasticity in the mesolimbic dopamine system.

Authors:  Mark J Thomas; Robert C Malenka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-04-29       Impact factor: 6.237

Review 7.  Brain circuitry and the reinstatement of cocaine-seeking behavior.

Authors:  Peter W Kalivas; Krista McFarland
Journal:  Psychopharmacology (Berl)       Date:  2003-03-22       Impact factor: 4.530

Review 8.  Recent understanding in the mechanisms of addiction.

Authors:  Peter W Kalivas
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

9.  Associative Learning Drives the Formation of Silent Synapses in Neuronal Ensembles of the Nucleus Accumbens.

Authors:  Leslie R Whitaker; Paulo E Carneiro de Oliveira; Kylie B McPherson; Rebecca V Fallon; Cleopatra S Planeta; Antonello Bonci; Bruce T Hope
Journal:  Biol Psychiatry       Date:  2015-08-14       Impact factor: 13.382

10.  Continuous intracerebroventricular infusion of the competitive NMDA receptor antagonist, LY235959, facilitates escalation of cocaine self-administration and increases break point for cocaine in Sprague-Dawley rats.

Authors:  Richard M Allen; Kristina A Uban; Elizabeth M Atwood; David S Albeck; Dorothy J Yamamoto
Journal:  Pharmacol Biochem Behav       Date:  2007-07-21       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.